Opportunity ID: 301696
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-18-006 |
| Funding Opportunity Title: | FDA Drug Residue Prevention Program (U18) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Consumer Protection Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | 9 |
| Assistance Listings: | 93.103 — Food and Drug Administration Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 15, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 16, 2018 |
| Current Closing Date for Applications: | May 16, 2018 |
| Archive Date: | Jun 15, 2018 |
| Estimated Total Program Funding: | $1,275,000 |
| Award Ceiling: | $175,000 |
| Award Floor: | $1,000 |
Eligibility
| Eligible Applicants: | State governments |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: | The intended outcome of this program is to advance efforts to improve and develop state drug residue prevention programs. It is necessary to provide assistance to state drug residue programs that need a stronger foundation to promote the prevention of illegal drug residues in animal derived foods through educational outreach and training.
This program is intended to ensure drug residue prevention programs are developed to protect consumer exposure to drug residues in the edible products of food animals and support activities related to drug residue prevention. In addition, these awards will assist state agencies to better direct their programs to reduce the outcomes of illegal drug residues in animal derived foods. This cooperative agreement program (CAP) will focus on outreach, education and training. In addition, grantees will focus on performing targeted on-site assessments related to drug residue violations and best practice visits to industry and individuals to communicate proper drug use and promote effective management practices for drug residue prevention. |
| Link to Additional Information: | Link to full announcement RFA-FD-18-006 |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Daniel Lukash
Grants Management Specialist Phone 240-402-7596 Email:daniel.lukash@fda.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Packages
| Agency Contact Information: | Daniel Lukash Grants Management Specialist Phone 240-402-7596 Email: daniel.lukash@fda.hhs.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.103 | RFA-FD-18-006 | Forms E | PKG00239300 | Mar 16, 2018 | May 16, 2018 | View |
Package 1
Mandatory forms
Optional forms
Share This Post, Choose Your Platform!
About the Author: osnqt
